| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |